Topic / Health / Summary

SUMMARY

The HOT Disruption

vitality_hero_eating-no

SUMMARY

Health Optimizer Therapies (HOTs): A New Era of Medicine


Throughout history, medicine has only been about damage control. That era is ending. We are now entering a new era of healthcare where medicine isn’t just about preventing and treating illness, but also about helping us be the best version of ourselves.

What follows here is a summary of the findings that are presented in depth across the other Rethinking Health web pages linked in the menu above. These are distilled into bulleted points for ease of access by both human and AI audiences. Note that a downloadable PDF version is also available at the menu link above.


Introduction

  • Health Optimizer Therapies (HOTs) are a new category of pharmaceuticals used not just to treat or prevent disease but to continuously maintain optimal health.
  • The same conceptual shift in the 20th Century that transformed food from mere sustenance into nutrition now applies in the 21st Century to medicine.
  • Living well with advanced HOTs will soon be as important as eating well with nutritious food.
  • GLP-1s are the first HOTs. Like the iPod, they are disruptive in their own right, but a much more impactful "iPhone Moment" is coming: HOTs that combine weight loss with muscle gain and other health benefits.
  • The first breakout combination of health optimizer therapies will be GLP-1s for weight loss combined with myostatin/activin inhibitors for muscle gain. This is very nearly the “diet and exercise in a bottle” prize that medical science has sought for generations.
  • The HOT disruption is not an incremental advance in dieting or exercise technology. It is a fundamental transformation with sweeping implications across many industries that will reshape societies and economies worldwide.
  • The HOT disruption is inevitable. The new technology offers an overwhelmingly competitive value proposition compared to every other form of weight loss and muscle gain method, product, or service that has come before.
  • Just as GLP-1s are not just for the treatment of obesity and type 2 diabetes, HOTs will not just be for the treatment of illness but instead will be utilized in small and/or periodic maintenance doses as a cornerstone of a healthy lifestyle.
  • By 2040, at least 1 billion adults worldwide will be using personalized HOTs under the guidance of their doctor to optimize their health and wellbeing.
  • HOTs will be especially valuable for middle-aged and elderly adults, who will experience weight loss, muscle gain, and other benefits as a stunningly effective anti-aging and rejuvenation therapy.
  • The preventative care value of HOTs to society and the economy will be so large that, like vaccines, the only sensible policy choice will be for governments to make them freely and universally accessible to all adults under the guidance of their doctor.
  • The universe of possible therapeutic molecules is so large that discovery of even better HOTs drugs than today’s most popular offerings is virtually certain.
  • Whether or not startup, open-source, and/or public drug development initiatives worldwide compete with major incumbent pharmaceutical firms in the development of HOTs drugs is a social choice, not a feature of the technology itself.
  • Nations should immediately enact policy to guarantee affordable, universal access to HOTs for all adults under the supervision of their doctor.
  • Widespread HOTs adoption would deliver enormous social, economic, environmental, and even geopolitical benefits.
  • Nations should fast-track regulatory approval for the development of new HOTs drugs, to help ensure their enormous benefits reach the public as soon as possible.
  • Increasing the individual healthfulness and resilience of the full adult population with HOTs will naturally increase the resilience of societies as a whole.
  • Widespread utilization of HOTs will help to rectify some the most pronounced community health disparities within and between societies.

HOT Technology

  • The first HOTs are GLP-1 pharmaceuticals, which first emerged in the early 2000s for treating type 2 diabetes.
Injectable GLP-1 Half Life Efficacy
Injectable GLP-1 Half Life Efficacy
Half Life (Hours)
 
 
Approved
 
Trials
  • Current leading GLP-1 drugs semaglutide (Ozempic/Wegovy) and tirzepatide (Zepbound/Mounjaro) already generate over $30 billion each in annual global revenues.
  • Semaglutide and tirzepatide outperform every prior weight loss option so decisively that the traditional dieting companies like WeightWatchers and Jenny Craig have collapsed.
  • The iPhone moment for HOTs is coming before 2030: the combination of GLP-1s with myostatin/activin blockers will enable simultaneous fat loss and muscle gain. This is very nearly the “diet and exercise in a bottle” that medical science has sought for generations.
  • AI is compressing pharmaceutical development, which means we are soon likely to see better HOTs that are even more effective with even fewer adverse side effects.
  • The manufacturing cost of semaglutide is already as low as $5 per dose. When semaglutide’s patent expires in 2026 in China, India, Brazil, and Canada, generic competition is likely to drive prices down by 95% within five years, just as it has with other medications such as statins.

Health Implications

  • Obesity is not just a weight problem. It is a root cause of type 2 diabetes, cardiovascular disease, cancer, cognitive decline, joint degeneration, sleep apnea, mental illness, and physical disability. An effective treatment for obesity is, therefore, an effective treatment for all of them.
  • The U.S. economy loses at least $573 billion per year to obesity in direct medical costs plus lost productivity.
  • GLP-1 users see whole-body benefits in at least eleven different organs, tissues, and systems, and early evidence now suggests they reduce cravings for alcohol, tobacco, opioids, gambling, and even doom-scrolling too.
  • GLP-1s are already 80–90% effective at preventing type 2 diabetes.
  • Heart disease affects nearly half of all American adults. GLP-1 users already see a 20% reduction in major adverse cardiovascular events. Benefits begin to emerge within weeks.
  • Nearly 40% of all U.S. cancer diagnoses are linked to obesity. HOTs will reduce cancer risk proportionally, and perhaps even more through additional reductions in systemic inflammation.
  • Obesity is a major cause of sleep apnea, and GLP-1s have thus shown over 50% reduction in sleep apnea events, with more than 40% of users achieving complete disease resolution.
  • HOTs may extend healthy lifespan by several years, compressing the period of late-life frailty and disability.
  • Middle-aged and elderly users  will experience the combined benefits of HOTs as stunningly effective longevity therapies.

Industry Implications

Healthcare Industry

  • Over $2.3 trillion of the $4.9 trillion in annual U.S. healthcare spending flows toward conditions that are either caused or worsened by obesity. A large decline in this spending will unavoidably impact the livelihoods of millions of people working in the healthcare industry.
  • Hospitals and healthcare providers that built their business models around managing the chronic disease consequences of obesity will see demand collapse over the next decade.
  • Global healthcare systems will begin a paradigm shift away from crisis management and optimization.
  • Demand for goods and services directly associated with obesity and type 2 diabetes treatment such as bariatric surgery (275,000 performed annually, at a cost of at least $1 billion) will collapse.

Dieting and Weight Loss Industries

  • HOTs have already disrupted the traditional dieting industry, with former majors like WeightWatchers and Jenny Craig bankrupt.
  • Demand for traditional dieting products and services that are expensive and ineffective will inevitably collapse.
  • The dieting and weight loss industry will have no choice but to refocus on HOTs-centered business models.

Fitness, Sports, and Recreation Industries

  • HOTs will enable adults to be more active because leaner, stronger people are more physically capable, more self-confident, and more likely to pursue sports and outdoor recreation.
  • The focus of the fitness industry, including gyms and studios, will shift from “getting fit” to “being fit and doing things.”
  • Traditional fitness business models built around weight loss and muscle building will need to pivot to capability and performance training, or face decline.
  • Outdoor recreation, sporting goods, and performance coaching will see strong growth.

Food and Beverage Industries

  • The food industry faces a decline not seen since rationing during World War II.
  • American adults spend over $900 billion per year on unhealthy “junk” food. A one-third reduction in junk food demand is a plausible consequence of widespread HOT adoption, and would represent $300 billion in annual revenue decline for the food and beverage industries.
  • HOT users don’t just eat less, they eat differently.
  • Fast food, sweetened beverages, confectionery, and full-service restaurants whose margins depend on alcohol and dessert sales face intense disruption pressure.

Agriculture Industries

  • Grain crops, sugar crops, and dairy are the agricultural industries whose food products will be most impacted by HOTs adoption.
  • Corn farming in particular, and the high-fructose corn syrup industry it feeds, faces pronounced structural decline in demand.

Potentially Addictive Products and Services Industries

  • The industries that supply potentially addictive products, including alcohol, tobacco, gambling, illicit drugs, collectively represent over $800 billion in annual U.S. revenues.
  • All of them face structural decline from widespread HOT adoption.

Insurance Industries

  • A healthier population means fewer private health and disability insurance claims.
  • Near-term profitability may increase (subject to regulatory strictures), but over time we should expect premiums to reprice downward and revenues to contract overall.

Social Implications

  • Lower-income communities suffer higher rates of obesity, substance use, and alcohol addiction because of structural disadvantages, including targeted marketing of cheap unhealthy food, food deserts, economic stress, limited access to health resources, and other factors.
  • Although HOTs do not fix these structural problems, they could nevertheless help millions live more healthfully.
  • Nearly 80% of all criminal offenders abuse drugs or alcohol. Almost 50% of prison inmates are clinically addicted. Alcohol is involved in 40% of all violent crimes.
  • The HOT disruption could significantly reshape the criminal justice sector by reducing substance abuse and addiction, improving millions of lives and saving tens of billions of dollars.
  • Nearly 60% of GLP-1 users report significant impacts on their romantic lives, with both positive and negative effects.
  • Attorneys and psychologists have already documented a rise in relationship friction and breakups among HOTs users.
  • When the HOTs disruption makes body composition more easily controllable, the cultural meanings of obesity.
  • Religious and cultural traditions around food, substance use, willpower, discipline, and temptation will all face new pressures and changing dynamics as a result of the HOTs disruption.

Economic Productivity

  • A leaner, stronger, healthier adult workforce produces more, misses fewer days, suffers fewer injuries, and remains productive until later in life.
  • The productivity gains from widespread HOT adoption will be largest among middle-aged and older workers whose productivity is most likely to have been diminished by ill-health.
  • The HOTs disruption will lead to a more productive workforce with lower spending on healthcare, disability, food assistance, and criminal justice.
  • Public investment in universal HOTs access under the guidance of a doctor is the obvious policy choice for every nation worldwide.

Geopolitical Implications

  • Food has been a source of conflict and a tool of power throughout human history.
  • A structural decline in global food demand, and especially for carbohydrate- and sugar-dense crops, will reshape international trade relationships and could destabilize nations dependent on food exports.
  • The HOT disruption is not happening in isolation. It arrives alongside simultaneous disruptions in energy, transportation, food systems, and labor.
  • The global geopolitical order built on current resource dependencies is being disrupted from many directions simultaneously.

Environmental Implications

  • If the 107 million obese Americans reduced their calorie intake by over 500 calories per day through HOT adoption, the resulting reduction in food production would free up at least 4.5 million acres of cropland. This is an area nearly the size of New Hampshire.
  • Reducing agricultural land use could translate into many dimensions of environmental benefit, including water consumption, emissions, soil contamination, water and air pollution, ecosystem health, and more.
  • Land freed from agricultural use represents an extraordinary opportunity for conservation, restoration, reforestation, and rewilding.

Choices and Call to Action

  • An estimated 60-65 million total deaths occur worldwide each year, and the share of all deaths attributed to obesity is now approaching 10%.
  • By reducing obesity, HOTs will not only prevent deaths, but also prevent the years suffering and loss leading up to those deaths.
  • The sheer scale of the global obesity epidemic means that every year which we delay making HOTs universally available to all adults is another year of enormous loss, suffering, and death worldwide that can now be avoided.
  • The sweeping benefits and enormous return on public investment in HOTs makes universal access a moral, economic, and strategic imperative for every nation.
  • HOTs should be viewed as a new kind of infrastructure that creates the enabling conditions for human health, productivity, and flourishing the same way roads, electricity, and clean water do.
  • Nations that act decisively can capture the staggering benefits of HOTs technologies for their people starting immediately, which will only help to position them for the other technology disruptions and transformations that lie ahead in this challenging era.
Disclaimer

The information provided in this report is for general informational and educational purposes only and is not intended to constitute medical advice, diagnosis, or treatment. This report does not establish a doctor-patient relationship. The content within this report regarding GLP-1 receptor agonists (or any other medical treatments) should not be used as a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment options. Never disregard professional medical advice or delay in seeking it because of something you have read in this report. The authors and publishers of this report make no representation or warranty, express or implied, regarding the accuracy, adequacy, validity, reliability, availability, or completeness of any information presented. Reliance on any information provided in this report is solely at your own risk.